A Histological and Clinical Study of MatriDerm® Use in Burn Reconstruction
Journal of Burn Care & Research · 2023
DOI: 10.1093/jbcr/irad024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Burn Care & Research, 2023. Verfasst von Kathryn Dickson und 9 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Mindelsohn Way, Edgbaston, Birmingham B15 2WB, UK. Hauptthemen laut MEDLINE: Burns, Skin, Artificial. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Dermal substitutes are well established in the reconstructive ladder. MatriDerm® (Dr. Otto Suwelack Skin & Health Care AG, Billerbeck, Germany) is a single-layer dermal substitute composed of a bovine collagen (type I, III, and V) and elastin hydrolysate, that allows for immediate split-thickness skin grafting (SSG). The aim of this study was to histologically characterize the integration of MatriDerm® when used during burns surgery reconstruction. Eight subjects with nine burn scars and one acute burn wound underwent reconstruction with MatriDerm® and an immediate SSG. MatriDerm® integration and skin graft take were assessed with serial biopsies performed at weeks 1, 2, 3, and 4 and months 2, 3, 6, 9, and 12. Biopsies were assessed with standard special stains and immunohistochemistry, and representative slides were imaged with a transmission electron microscope. Patient satisfaction and clinical scar outcome were assessed with the Vancouver Scar Scale and a patient questionnaire. Histological analysis showed similar stages of wound healing as shown in other dermal templates but on a different timescale. There is early evidence of vascularization and an inflammatory infiltrate in the first 2 weeks. MatriDerm® is resorbed earlier than other dermal substitutes, with evidence of resorption at week 3, to be completely replaced by a neodermis at 2 months. The use of MatriDerm® in reconstruction with immediate skin grafting is supported histologically with early evidence of vascularization to support an epidermal autograft. Future histological studies may help further characterize the ideal dermal substitute.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University Hospital Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Mindelsohn Way, Edgbaston, Birmingham B15 2WB, UK.
- Scar Free Foundation Centre for Conflict Wound Research, University Hospital Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Mindelsohn Way, Edgbaston, Birmingham B15 2WB, UK.
- Institute of Inflammation and Aging, University of Birmingham, Birmingham B15 2TT, UK.
ORCID-Profile: Kathryn Dickson, Abdulrazak Abdulsalam, Ezekwe Amirize, Hadyn K N Kankam, Amy Bamford
Zitieren
APA
Dickson, K., Lee, K. C., Abdulsalam, A., Amirize, E., Kankam, H. K. N., Ter Horst, B., Gardiner, F., Bamford, A., Hejmadi, R. K., & Moiemen, N. (2023). A Histological and Clinical Study of MatriDerm® Use in Burn Reconstruction. Journal of Burn Care & Research. https://doi.org/10.1093/jbcr/irad024
Vancouver
Dickson K, Lee KC, Abdulsalam A, Amirize E, Kankam HKN, Ter Horst B, et al. A Histological and Clinical Study of MatriDerm® Use in Burn Reconstruction. Journal of Burn Care & Research. 2023. doi:10.1093/jbcr/irad024
BibTeX
@article{Dickson2023,
author = {Dickson, Kathryn and Lee, Kwang Chear and Abdulsalam, Abdulrazak and Amirize, Ezekwe and Kankam, Hadyn K N and Ter Horst, Britt and Gardiner, Fay and Bamford, Amy and Hejmadi, Rahul K and Moiemen, Naiem},
title = {A Histological and Clinical Study of MatriDerm® Use in Burn Reconstruction},
journal = {Journal of Burn Care & Research},
year = {2023},
doi = {10.1093/jbcr/irad024}
}
EUVIMED